Bristol Myers’ BMY cardiovascular portfolio currently comprises blockbuster drugs Eliquis and Camzyos. The company recently ...

A recent study in The New England Journal of Medicine reported that Eliquis, a blood-thinning drug, poses a lower risk of dangerous bleeding compared to Xarelto in patients with deep blood clots. The ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The drug Eliquis, ...

A trial directly comparing two commonly used blood-thinning drugs found that one carries a lower risk of dangerous bleeding ‌in patients with clots in veins deep in the body, researchers reported in ...

March 13 (Reuters) - A trial directly comparing Eliquis and Xarelto - two commonly used blood-thinning drugs from the same class of medicines - found that Eliquis carries a clearly lower risk of ...

March 13 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...

Add Yahoo as a preferred source to see more of our stories on Google. A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, U.S. January 9, ...